International Journal of Critical Illness and Injury Science最新文献

筛选
英文 中文
Early onset delirium incidence and risk factors in hematology oncology patients admitted to the intensive care unit: A retrospective cohort study. 入住重症监护室的血液肿瘤患者的早发性谵妄发病率和危险因素:一项回顾性队列研究。
International Journal of Critical Illness and Injury Science Pub Date : 2022-10-01 Epub Date: 2022-12-26 DOI: 10.4103/ijciis.ijciis_35_22
Rachel C Klosko, Joshua R Arnold, Claire V Murphy, Jessica Brimmer, Natalie Hagy, Matthew C Exline, Eric McLaughlin, Jessica L Elefritz
{"title":"Early onset delirium incidence and risk factors in hematology oncology patients admitted to the intensive care unit: A retrospective cohort study.","authors":"Rachel C Klosko,&nbsp;Joshua R Arnold,&nbsp;Claire V Murphy,&nbsp;Jessica Brimmer,&nbsp;Natalie Hagy,&nbsp;Matthew C Exline,&nbsp;Eric McLaughlin,&nbsp;Jessica L Elefritz","doi":"10.4103/ijciis.ijciis_35_22","DOIUrl":"10.4103/ijciis.ijciis_35_22","url":null,"abstract":"<p><strong>Background: </strong>Delirium occurs frequently in intensive care unit (ICU) patients; however, there are limited data evaluating its impact on critically ill hematology-oncology patients. We aimed to determine the incidence and risk factors for early-onset delirium development in hematology-oncology patients admitted to the ICU.</p><p><strong>Methods: </strong>This single-center, retrospective cohort study evaluated the primary outcome of incident delirium within 7 days of ICU admission in adults admitted to the hematology-oncology medical or surgical ICU. Patients with delirium (DEL) were compared to those without (No-DEL) for evaluation of secondary endpoints including hospital mortality, ICU, and hospital length of stay (LOS). Multivariable logistic regression modeling was performed to identify independent risk factors for delirium.</p><p><strong>Results: </strong>Delirium occurred in 125 (51.2%) of 244 patients. Inhospital mortality was significantly higher in the DEL vs. No-DEL group (32.8% vs. 15.1%, <i>P</i> = 0.002). Median (1<sup>st</sup> and 3<sup>rd</sup> quartiles) ICU and hospital LOS were significantly longer in the delirium group, respectively (6 [4-10] days vs. 3 [2-5] days, <i>P</i> < 0.001, and 21 [14-36] days vs. 12 [8-22] days, <i>P</i> < 0.001). Higher Sequential Organ Failure Assessment score, high-dose corticosteroids, mechanical ventilation (MV), and brain metastases were each independently, associated with an increased delirium risk.</p><p><strong>Conclusion: </strong>Hematology-oncology patients admitted to the ICU frequently develop delirium. Consistent with literature in nonhematology-oncology critically ill patients, identified independent risk factors for delirium were MV and organ dysfunction. Risk factors unique to the critically ill hematology-oncology patient population include high-dose corticosteroids and brain metastases. Further research is needed to evaluate strategies to mitigate delirium development in this population based on risk assessment.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"12 4","pages":"190-196"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910111/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10698518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary embolism in patients with severe COVID-19 treated with systemic low-dose thrombolytic therapy: A case series. 全身低剂量溶栓治疗重症新冠肺炎患者的肺栓塞:一个病例系列。
International Journal of Critical Illness and Injury Science Pub Date : 2022-10-01 Epub Date: 2022-12-26 DOI: 10.4103/ijciis.ijciis_53_22
I Gusti Ngurah Mahaalit Aribawa, Christopher Ryalino, Adinda Putra Pradhana, Putu Utami Dewi, Cyndiana Widia Dewi Sinardja, Ni Kadek Mulyantari
{"title":"Pulmonary embolism in patients with severe COVID-19 treated with systemic low-dose thrombolytic therapy: A case series.","authors":"I Gusti Ngurah Mahaalit Aribawa,&nbsp;Christopher Ryalino,&nbsp;Adinda Putra Pradhana,&nbsp;Putu Utami Dewi,&nbsp;Cyndiana Widia Dewi Sinardja,&nbsp;Ni Kadek Mulyantari","doi":"10.4103/ijciis.ijciis_53_22","DOIUrl":"10.4103/ijciis.ijciis_53_22","url":null,"abstract":"<p><p>Coronavirus disease 2019 (COVID-19) has been associated with respiratory failure and high mortality. Hypercoagulability and thromboembolic complications have been found in a high percentage of patients amongst which, pulmonary embolism (PE) is the most common. Currently, there are no guidelines on using thrombolysis therapy in COVID-19 patients who developed PE. We present five survivors aged 30-75 years old with confirmed COVID-19. All cases were proven by computed tomography pulmonary angiogram (CTPA) to have PE treated with low-dose recombinant tissue plasminogen activator (rtPA). PE should be suspected in all COVID-19 patients with rapid worsening of dyspnea, desaturation, unexplained shock, and increased level of D-dimer and fibrinogen. In our cases, PE developed despite preventative anticoagulation regimens with low molecular weight heparin. After thrombolytic therapy, all patients showed improvement in partial-arterial-oxygen-pressure to inspired oxygen-fraction ratio (arterial partial pressure of oxygen/inspired oxygen fraction ratio). D-dimer showed elevation after thrombolytic therapy and decreased in the following days. Fibrinogen levels decreased following thrombolytic therapy. Current anticoagulation regimens seem insufficient to halt the course of thrombosis, and thrombolytic therapy may be beneficial for patients with severe COVID-19 and PE. Systemic thrombolysis therapy is a double-edged sword, and clinicians must balance between benefit and risk of bleeding.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"12 4","pages":"235-238"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910114/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10705130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Fulminant acute fatty liver of pregnancy presenting with multi-organ failure: A case series. 妊娠合并多器官衰竭的暴发性急性脂肪肝:一系列病例。
International Journal of Critical Illness and Injury Science Pub Date : 2022-10-01 Epub Date: 2022-12-26 DOI: 10.4103/ijciis.ijciis_31_22
Sai Saran, Saumitra Misra, Suhail Sarwar Siddiqui, Avinash Agrawal, Mohan Gurjar, Ajay Kumar Patwa, Syed Nabeel Muzaffar
{"title":"Fulminant acute fatty liver of pregnancy presenting with multi-organ failure: A case series.","authors":"Sai Saran,&nbsp;Saumitra Misra,&nbsp;Suhail Sarwar Siddiqui,&nbsp;Avinash Agrawal,&nbsp;Mohan Gurjar,&nbsp;Ajay Kumar Patwa,&nbsp;Syed Nabeel Muzaffar","doi":"10.4103/ijciis.ijciis_31_22","DOIUrl":"10.4103/ijciis.ijciis_31_22","url":null,"abstract":"<p><p>Liver disease in pregnancy can be classified into pregnancy-related, liver disease coincident with pregnancy or preexisting liver disease. Acute fatty liver of pregnancy (AFLP) is a rare liver disorder that is caused by defects in mitochondrial beta (β) oxidation of fatty acids. In view of its fulminant presentation and rapid progression to multiple organ failure (MOF), AFLP carries high maternal and fetal mortality. These patients are commonly present in the third trimester of pregnancy with gastrointestinal symptoms and complications such as hypoglycemia, lactic acidosis, hyperammonemia, leukocytosis, liver dysfunction, coagulopathy, and renal dysfunction. Diagnosis is mostly based on the Swansea diagnostic criteria and by excluding other etiologies of liver dysfunction. Liver biopsy is rarely performed owing to underlying coagulopathy and thrombocytopenia. In this case series, we intend to share our experience of managing four cases of AFLP that were admitted to the intensive care unit with fetal demise and MOF.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"12 4","pages":"239-243"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910109/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10705131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors and clinical outcomes of carbapenem-resistant Klebsiella pneumonia infection in intensive care unit: A retrospective observational study in a tertiary care hospital in Eastern India. 重症监护室中耐碳青霉烯类克雷伯菌肺炎感染的危险因素和临床结果:印度东部一家三级护理医院的回顾性观察性研究。
International Journal of Critical Illness and Injury Science Pub Date : 2022-10-01 Epub Date: 2022-12-26 DOI: 10.4103/ijciis.ijciis_34_22
Sagarika Panda, Abhilash Dash, Pritam Chhotray, Biswajit Nayak, Tatikonda Chandra Mouli, Shakti Bedanta Mishra
{"title":"Risk factors and clinical outcomes of carbapenem-resistant <i>Klebsiella pneumonia</i> infection in intensive care unit: A retrospective observational study in a tertiary care hospital in Eastern India.","authors":"Sagarika Panda,&nbsp;Abhilash Dash,&nbsp;Pritam Chhotray,&nbsp;Biswajit Nayak,&nbsp;Tatikonda Chandra Mouli,&nbsp;Shakti Bedanta Mishra","doi":"10.4103/ijciis.ijciis_34_22","DOIUrl":"10.4103/ijciis.ijciis_34_22","url":null,"abstract":"<p><strong>Background: </strong>Carbapenem-resistant Enterobacteriaceae, especially <i>Klebsiella pneumonia</i>, have become a severe global problem with a significant threat to public health, but few studies have investigated the risk factors and epidemiology of carbapenem-resistant <i>K. pneumonia</i> (CRKP) infections in India.</p><p><strong>Methods: </strong>We performed a retrospective observational study of 224 participants with <i>K. pneumoniae</i> who were admitted to the medical intensive care unit (ICU) of Institute of Medical Sciences and SUM Hospital, Bhubaneswar, India, between January 1 and December 30, 2020. Antibiotic susceptibility testing was done by automated broth microdilution VITEK<sup>®</sup> 2 (BioMerieux, Inc., Hazelwood, USA). The Clinical and Laboratory Standards Institute document M100-S22 (January 2020) was used to interpret antimicrobial susceptibility testing. Data were obtained from paper medical records.</p><p><strong>Results: </strong>Two hundred and twenty-four subjects with culture-positive for <i>K. pneumonia</i> were retrieved during the study period, out of which 108 had CRKP. The risk factors for univariate analysis were Acute Physiology and Chronic Health Evaluation II, ICU length of stay (LOS), invasive mechanical ventilator days, central venous catheter days, and arterial line days. The multivariate analysis showed invasive mechanical ventilation and ICU LOS were independent risk factors for CRKP infection. Mortality in the CRKP group was 48 (44%) compared to 27 (23%) in the carbapenem-sensitive <i>K. pneumonia</i> (CSKP) group, which was statistically significant (<i>P</i> < 0.01).</p><p><strong>Conclusion: </strong>Infection due to CRKP in the ICU was associated with 1.9 times higher mortality as compared to CSKP. Invasive mechanical ventilation and ICU LOS were found to be independent risk factors for CRKP infection.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"12 4","pages":"217-221"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910118/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10705134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation between serum surfactant protein-D level with respiratory compliance and acute respiratory distress syndrome in critically ill COVID-19 Patients: A retrospective observational study. 危重新冠肺炎患者血清表面活性物质蛋白-D水平与呼吸顺应性和急性呼吸窘迫综合征的相关性:一项回顾性观察研究。
International Journal of Critical Illness and Injury Science Pub Date : 2022-10-01 Epub Date: 2022-12-26 DOI: 10.4103/ijciis.ijciis_27_22
Jayadi, Prananda Surya Airlangga, Edward Kusuma, Christrijogo Soemartono Waloejo, Agustina Salinding, Pudji Lestari
{"title":"Correlation between serum surfactant protein-D level with respiratory compliance and acute respiratory distress syndrome in critically ill COVID-19 Patients: A retrospective observational study.","authors":"Jayadi,&nbsp;Prananda Surya Airlangga,&nbsp;Edward Kusuma,&nbsp;Christrijogo Soemartono Waloejo,&nbsp;Agustina Salinding,&nbsp;Pudji Lestari","doi":"10.4103/ijciis.ijciis_27_22","DOIUrl":"10.4103/ijciis.ijciis_27_22","url":null,"abstract":"<p><strong>Background: </strong>Acute respiratory distress syndrome (ARDS) is one of the manifestations of severe coronavirus disease 2019 (COVID-19) with low respiratory compliance and poor oxygenation as main characteristics and mortality rate of 50%-94%. Surfactants, including surfactant protein D (SP-D), have a role in maintaining respiratory compliance. This study aimed to analyze the relationship between serum SP-D levels with respiratory compliance and ARDS in patients with critically ill COVID-19 pneumonia.</p><p><strong>Methods: </strong>This study was a cross-sectional study. Subjects were adult reverse transcription-polymerase chain reaction-confirmed COVID-19 patients who had ARDS treated with invasive mechanical ventilation. All data were obtained from medical records. Statistical analysis was done using Spearman test, Mann-Whitney test, and receiver operating characteristic curve.</p><p><strong>Results: </strong>Serum level of SP-D was significantly correlated with static respiratory compliance (<i>P</i> = 0.009; correlation coefficient [rs] = 0.467). Serum SP-D levels correlated with ARDS severity (<i>P</i> < 0.001). SP-D levels had a very strong diagnostic value for ARDS severity, with an optimal cutoff value of 44.24 ng/mL (sensitivity 92.3%; specificity 94.1%). ARDS severity also correlated significantly with respiratory compliance (<i>P</i> = 0.005; correlation coefficient 0.496).</p><p><strong>Conclusion: </strong>Higher serum SP-D levels were associated with lower respiratory compliance, ARDS severity, and may be utilized diagnostically to identify patients with severe ARDS.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"12 4","pages":"204-210"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910112/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10714129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Systemic thrombolytics as rescue therapy for COVID-19 patients with acute respiratory distress syndrome: A retrospective observational study. 全身溶栓剂作为新冠肺炎急性呼吸窘迫综合征患者的抢救疗法:一项回顾性观察研究。
International Journal of Critical Illness and Injury Science Pub Date : 2022-10-01 Epub Date: 2022-12-26 DOI: 10.4103/ijciis.ijciis_45_22
Prathibha Gowda Ashwathappa, Ipe Jacob, Pradeep Rangappa, Karthik Rao
{"title":"Systemic thrombolytics as rescue therapy for COVID-19 patients with acute respiratory distress syndrome: A retrospective observational study.","authors":"Prathibha Gowda Ashwathappa,&nbsp;Ipe Jacob,&nbsp;Pradeep Rangappa,&nbsp;Karthik Rao","doi":"10.4103/ijciis.ijciis_45_22","DOIUrl":"10.4103/ijciis.ijciis_45_22","url":null,"abstract":"<p><strong>Background: </strong>Coronavirus disease 2019 (COVID-19) pneumonia with severe acute respiratory distress syndrome (ARDS) is often associated with a progressive respiratory failure that is refractory to maximal ventilatory support and other ARDS strategies. Studies show evidence of a hypercoagulable state in COVID-19 patients, including capillary thrombosis and alveolar fibrin deposits which impede normal gas exchange. In this context, thrombolysis is considered as a salvage therapy to rescue critically hypoxemic patients.</p><p><strong>Methods: </strong>In this retrospective observational study, the efficacy of thrombolysis on outcome of COVID-19 ARDS with respiratory failure was analyzed. Patients with severe ARDS and d-dimer levels of 5 μg/ml or above were initiated on alteplase, as a 25 mg bolus followed by a 25 mg infusion over 22 h. Primary outcome was intensive care unit (ICU) mortality and secondary outcomes were change in PaO2/FiO2 24 h after thrombolysis, avoidance of intubation, ventilator free days (VFD), and ICU and hospital length-of-stay (LOS).</p><p><strong>Results: </strong>Thirteen out of 34 patients with severe COVID ARDS underwent thrombolysis. They had lower ICU mortality than non-thrombolysed patients (23.1% vs. 71.4%, <i>P</i> = 0.006), greater percentage improvement in PaO2/FiO2 (116% vs. 31.5%, <i>P</i> = 0.002), more VFDs (13 days vs. 0 day, <i>P</i> = 0.004), and lesser requirement for intubation (23.1% vs. 76.2%, <i>P</i> = 0.004). ICU and hospital LOS were similar.</p><p><strong>Conclusion: </strong>Thrombolysis can be considered as a rescue therapy for nonintubated COVID-19 ARDS patients with severe hypoxemic respiratory failure, who show evidence of a procoagulant state. Larger studies are needed before inclusion into the regular treatment protocol for COVID-19 patients.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"12 4","pages":"197-203"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910116/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10714131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the effects of vitamin C and thiamine on refractory hypotension in patients with sepsis: A randomized controlled trial. 比较维生素C和硫胺素对脓毒症患者难治性低血压的影响:一项随机对照试验。
International Journal of Critical Illness and Injury Science Pub Date : 2022-07-01 DOI: 10.4103/ijciis.ijciis_107_21
N Nandhini, Deepak Malviya, Samiksha Parashar, Chandrakant Pandey, Soumya Sankar Nath, Manoj Tripathi
{"title":"Comparison of the effects of vitamin C and thiamine on refractory hypotension in patients with sepsis: A randomized controlled trial.","authors":"N Nandhini,&nbsp;Deepak Malviya,&nbsp;Samiksha Parashar,&nbsp;Chandrakant Pandey,&nbsp;Soumya Sankar Nath,&nbsp;Manoj Tripathi","doi":"10.4103/ijciis.ijciis_107_21","DOIUrl":"https://doi.org/10.4103/ijciis.ijciis_107_21","url":null,"abstract":"<p><strong>Background: </strong>The study aimed to compare the effect of thiamine and ascorbic acid (AA) on mortality, sequential organ failure assessment (SOFA) score, duration and dose of vasopressor support, and need for renal replacement therapy (RRT) in patients with septic shock with refractory hypotension.</p><p><strong>Methods: </strong>Consenting adult patients with septic shock and refractory hypotension were included in this study. Patients were divided into three groups: Group A received 100 ml of balanced salt solution 8 hourly, Group B received 2 mg/kg of thiamine 8 hourly, Group C received 25 mg/kg of AA 8 hourly intravenous (IV) for 72 h. All patients received IV infusion of hydrocortisone 200 mg/day for 72 h. Serum lactate, dose and duration of vasopressor support, SOFA score, need for RRT and hospital mortality were analyzed.</p><p><strong>Results: </strong>The SOFA Score was significantly lower in Group B than in Group A and C at 24, 48, and 72 h. Dosage of norepinephrine was lower in Group B at 66 h and after that, whereas in Groups A and C, it was comparable at all time points. Mortality in Group B was significantly lower but comparable in Groups A and C. The need for RRT was significantly lower in Group B (44%) compared to the control group (88%) but comparable in Group C (76%).</p><p><strong>Conclusion: </strong>In patients with septic shock treated with hydrocortisone, co-treatment with thiamine led to earlier correction of organ dysfunction, reduced need for RRT, and improved mortality compared to patients treated with AA or balanced salt solution. The addition of AA did not yield measurable benefits beyond hydrocortisone alone.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"12 3","pages":"138-145"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728072/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10393406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Point-of-care versus central laboratory measurements of electrolytes and hemoglobin: A prospective observational study in critically ill patients in a tertiary care hospital. 点护理与中心实验室测量电解质和血红蛋白:对三级护理医院危重患者的前瞻性观察研究。
International Journal of Critical Illness and Injury Science Pub Date : 2022-07-01 DOI: 10.4103/ijciis.ijciis_2_22
Sangeeta Sahoo, Jyotiranjan Sahoo, Neha Singh, Upendra Hansda, Satyabrata Guru, Nitish Topno
{"title":"Point-of-care versus central laboratory measurements of electrolytes and hemoglobin: A prospective observational study in critically ill patients in a tertiary care hospital.","authors":"Sangeeta Sahoo,&nbsp;Jyotiranjan Sahoo,&nbsp;Neha Singh,&nbsp;Upendra Hansda,&nbsp;Satyabrata Guru,&nbsp;Nitish Topno","doi":"10.4103/ijciis.ijciis_2_22","DOIUrl":"https://doi.org/10.4103/ijciis.ijciis_2_22","url":null,"abstract":"<p><strong>Background: </strong>A blood gas analyzer is a point-of-care (POC) testing device used in the Emergency Department (ED) to manage critically ill patients. However, there were differences in results found from blood gas analyzers for hemoglobin (Hgb) and electrolytes parameters. We conducted a comparative validity study in ED in patients who had requirements of venous gas analysis, complete blood count, and electrolytes. The objective was to find the correlation of Hgb, sodium (Na<sup>+</sup>), and potassium (K<sup>+</sup>) values between the blood gas analyzer and laboratory autoanalyzer.</p><p><strong>Methods: </strong>A total of 206 paired samples were tested for Hgb, Na<sup>+</sup>, and K<sup>+</sup>. Total 4.6 ml of venous blood was collected from each participant, 0.6 ml was used for blood gas analysis as POC testing and 4 ml was sent to the central laboratory for electrolyte and Hgb estimation.</p><p><strong>Results: </strong>The mean difference between POC and laboratory method was 0.608 ± 1.41 (95% confidence interval [CI], 0.41-0.80; <i>P</i> < 0.001) for Hgb, 0.92 ± 3.5 (95% CI, 0.44-1.40) for Na<sup>+</sup>, and 0.238 ± 0.62 (95% CI, -0.32-0.15; <i>P</i> < 0.001) for K<sup>+</sup>. POC testing and laboratory method showed a strong positive correlation with Pearson correlation coefficient (<i>r</i>) of 0.873, 0.928, and 0.793 for Hgb, Na<sup>+</sup>, and K<sup>+</sup>, respectively (<i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>Although there was a statistical difference found between the two methods, it was under the United States Clinical Laboratory Improvement Amendment range. Hence, starting the therapy according to the blood gas analyzer results may be beneficial to the patient and improve the outcome.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"12 3","pages":"160-164"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728077/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10393407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation of time to death after admission to an intensive care unit and factors associated with mortality: A retrospective longitudinal study. 重症监护病房入院后死亡时间及死亡率相关因素的评估:一项回顾性纵向研究。
International Journal of Critical Illness and Injury Science Pub Date : 2022-07-01 DOI: 10.4103/ijciis.ijciis_98_21
Ana Luiza Mezzaroba, Alexandre S Larangeira, Fernanda K Morakami, Jair Jesus Junior, Amanda A Vieira, Marina M Costa, Fernanda M Kaneshima, Giovana Chiquetti, Ulisses E Colonheze, Giovanna C S Brunello, Lucienne T Q Cardoso, Tiemi Matsuo, Cintia M C Grion
{"title":"Evaluation of time to death after admission to an intensive care unit and factors associated with mortality: A retrospective longitudinal study.","authors":"Ana Luiza Mezzaroba,&nbsp;Alexandre S Larangeira,&nbsp;Fernanda K Morakami,&nbsp;Jair Jesus Junior,&nbsp;Amanda A Vieira,&nbsp;Marina M Costa,&nbsp;Fernanda M Kaneshima,&nbsp;Giovana Chiquetti,&nbsp;Ulisses E Colonheze,&nbsp;Giovanna C S Brunello,&nbsp;Lucienne T Q Cardoso,&nbsp;Tiemi Matsuo,&nbsp;Cintia M C Grion","doi":"10.4103/ijciis.ijciis_98_21","DOIUrl":"https://doi.org/10.4103/ijciis.ijciis_98_21","url":null,"abstract":"<p><strong>Background: </strong>Among nonsurvivors admitted to the intensive care unit (ICU), some present early mortality while other patients, despite having a favorable evolution regarding the initial disease, die later due to complications related to hospitalization. This study aims to identify factors associated with the time until death after admission to an ICU of a university hospital.</p><p><strong>Methods: </strong>Retrospective longitudinal study that included adult patients admitted to the ICU between January 1, 2008, and December 31, 2017. Nonsurviving patients were divided into groups according to the length of time from admission to the ICU until death: Early (0-5 days), intermediate (6-28 days), and late (>28 days). Patients were considered septic if they had this diagnosis on admission to the ICU. Simple linear regression analysis was performed to evaluate the association between time to death over the years of the study. Multivariate cox regression was used to assess risk factors for the outcome in the ICU.</p><p><strong>Results: </strong>In total, 6596 patients were analyzed. Mortality rate was 32.9% in the ICU. Most deaths occurred in the early (42.8%) and intermediate periods (47.9%). Patients with three or more dysfunctions on admission were more likely to die early (<i>P</i> < 0.001). The diagnosis of sepsis was associated with a higher mortality rate. The multivariate analysis identified age >60 years (hazard ratio [HR] 1.009), male (HR 1.192), mechanical ventilation (HR 1.476), dialysis (HR 2.297), and sequential organ failure assessment >6 (HR 1.319) as risk factors for mortality.</p><p><strong>Conclusion: </strong>We found a higher proportion of early and intermediate deaths in the study period. The presence of three or more organ dysfunctions at ICU admission was associated with early death. The diagnosis of sepsis evident on ICU admission was associated with higher mortality.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"12 3","pages":"121-126"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728075/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10332680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What's new in critical illness and injury science? Resource allocation and very short intensive care unit stays. 重症与损伤科学有哪些新进展?资源分配和极短的重症监护室停留时间。
International Journal of Critical Illness and Injury Science Pub Date : 2022-07-01 Epub Date: 2022-09-20 DOI: 10.4103/ijciis.ijciis_61_22
Andrew C Miller
{"title":"What's new in critical illness and injury science? Resource allocation and very short intensive care unit stays.","authors":"Andrew C Miller","doi":"10.4103/ijciis.ijciis_61_22","DOIUrl":"10.4103/ijciis.ijciis_61_22","url":null,"abstract":"","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"12 3","pages":"119-120"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728069/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10682383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信